In HER2-positive breast cancer, the ERBB2 amplification leads to an overexpression of the HER2 protein at the cell plasma membrane, this large amount of HER2 increases the activation of downstream proliferating signaling pathways by HER2 homo- or heterodimers [2]. This evidence concerns the gene ERBB2 and breast carcinoma.